Novan: Funding, Investors & Team (Sep 2026)
Novan utilizes nano-particles to package nitric oxide, an antibacterial compound, in order to transport therapeutic agents to specific areas of the body. The company employs its unique nitric oxide-based science and technology platform to develop groundbreaking treatments for medical needs that remain unmet. Novan is dedicated to harnessing the body's capabilities to create safe and efficient therapies. In addition to their internal scientific team, the company collaborates with strategic partners worldwide to fully utilize the power of nitric oxide and create technologies that address currently overlooked medical conditions. Novan was established in 2008 and operates from Morrisville, North Carolina.
Novan has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Novan Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Novan Funding Rounds
Novan Founders and Leadership Team
No contact details are on record for this team yet.
Novan Funding Compared to Other Biotechnology Startups
Novan's latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Novan in Biotechnology and Morrisville
Companies Similar to Novan
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Novan Funding FAQs
What does Novan do?
Novan utilizes nano-particles to package nitric oxide, an antibacterial compound, in order to transport therapeutic agents to specific areas of the body. The company employs its unique nitric oxide-based science and technology platform to develop groundbreaking treatments for medical needs that remain unmet. Novan is dedicated to harnessing the body's capabilities to create safe and efficient therapies. In addition to their internal scientific team, the company collaborates with strategic partners worldwide to fully utilize the power of nitric oxide and create technologies that address currently overlooked medical conditions. Novan was established in 2008 and operates from Morrisville, North Carolina.
How much funding has Novan raised?
Novan has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Jul 2023.
When did Novan last raise funding?
Novan's most recent funding round on record is an undisclosed round of $15.0M, announced in Jul 2023.
Who is the CEO of Novan?
Yvan Rugamba is listed as CEO at Novan.
Where is Novan headquartered?
Novan is based in Morrisville, North Carolina, United States.
How many employees does Novan have?
Novan is in the 101-250 employee band.
How does Novan's funding compare to other Biotechnology startups?
Novan's latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Novan Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Novan is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.